Vyhľadať

Vaše výsledky

Zobrazuje sa 10 z 17 výsledky

In September 2020, as part of the fight against cancer and to protect the health of workers in a number of industries, the European Commission proposed to amend the Carcinogens and Mutagens Directive (Directive 2004/37/EC), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. On 16 December 2021, after interinstitutional negotiations, the Council and the European Parliament reached a provisional agreement ...

The Carcinogens and Mutagens Directive is being updated for the fourth time, as part of the fight against cancer and to protect the health of workers in a number of industries. A trilogue agreement on the proposal sets new exposure limits for a range of hazardous substances. The European Parliament is expected to vote on the provisional agreement during its plenary session in February.

Protecting workers from asbestos

V stručnosti 13-10-2021

Asbestos is the one of the main causes of work-related cancers, despite its EU-wide ban in 2005. Asbestos-related risks persist and will be a health-risk factor in the context of the European Green Deal 'renovation wave', aimed at helping make buildings fit for a climate-neutral Europe. A legislative-initiative report setting out proposals for a 'European strategy for the removal of all asbestos' (ESRAA) is expected to be put to the vote during the October II plenary session.

Protecting workers from asbestos

Hĺbková analýza 29-03-2021

Asbestos is responsible for more than half of the deaths from occupational cancer in the world. Since 2005 Asbestos is banned in Europe. The risks remain, because of the maintenance or demolition work on older buildings and their renovation (increasing energy efficiency) result in substantial exposure to asbestos and many people still work and live in asbestos contaminated buildings.

The impact assessment (IA) defines clearly the problem and its underlying drivers. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable and/or justified. However, the IA would have benefited from providing greater clarity on those components that were either included in (short-term exposure limit values) or excluded (biological limit values) from the preferred options. The analysis of impacts focuses on their economic and social dimension, mainly ...

The European Commission has proposed to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing substances. The initiative is proceeding in steps. The first proposal of May 2016 covered 13 priority chemical agents, the second, of January 2017, a further seven. The current (third) proposal addresses an additional five. Broad discussions with scientists and the social partners fed into all three ...

The European Commission is undertaking a phased process to amend Directive 2004/37/EC (the Carcinogens and Mutagens Directive), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The third proposal to amend the directive addresses a further five agents. The agreement on the proposal reached after trilogue negotiations now needs to be confirmed by Parliament, with a vote expected to take place during the ...

The European Commission has proposed to amend Directive 2004/37/EC, by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The initiative is proceeding in steps. The first proposal, submitted in May 2016, covered 13 priority chemical agents. The current (second) proposal addresses a further seven agents. Broad discussions with scientists and the social partners fed into both proposals. On the whole, trade ...

This detailed appraisal focuses on the process and evidence base used in the IA for setting the limit values for cadmium and beryllium, notably in light of some knowledge gaps and methodological challenges identified in the IA in relation to the number of workers exposed and the estimation of the burden of disease. The appraisal concludes that the IA has relied on a vast and updated amount of information, including scientific journals, guidelines, manuals, surveys, published by authoritative research ...

The impact assessment (IA) accompanying the proposal for a third revision of the carcinogens and mutagens Directive 2004/37/EC clearly defines the problem to be addressed. However, it would have benefited from providing more comprehensive explanations of its evolution without EU action. The objectives appear to be relevant, sufficiently measurable, achievable, though not time-bound. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable, and consistent ...